• 1 January 1982
    • journal article
    • research article
    • Vol. 59  (1) , 179-184
Abstract
The cycling of blood cell counts in gray collie dogs with cyclic hematopoiesis can be eliminated by treatment with oral Li2CO3. To explore the mechanism by which Li alters this stem cell disorder, studies of bone marrow granulocyte-macrophage progenitor cells (CFU-C), neutrophil colony-forming cells (neutrophilic CFU-C) and colony-stimulating activity (CSA) were performed. In untreated dogs, the proportions of CFU-C fluctuated cyclically, but the cyclic fluctuations in neutrophil colony-forming cells were even more marked, with numbers decreasing to undetectable levels during each period of neutrophilia. Dogs on Li did not cycle the numbers of total or neutrophilic CFU-C. 3H-thymidine suicide rates were not altered by treatment with Li. Serum CSA levels and bone marrow cell elaboration of CSA were not increased by Li. Evidently, Li corrects cyclic neutropenia by a direct effect on the differentiation and proliferation of CFU-C; normalization of the proportion of CFU-C that enter neutrophilopoiesis appears to be an important effect of the Li therapy.